
Colorado Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivatives (CBD, THC), By Cultivation (Indoor Cultivation, Greenhouse Cultivation), By End Use (Recreational, Medical), And Segment Forecasts, 2025 - 2030
Description
Colorado Legal Cannabis Market Growth & Trends
The colorado legal cannabis market size is projected to reach USD 5.53 billion by 2030, expanding at a CAGR of 12.9% from 2025 to 2030, according to a report by Grand View Research, Inc. The growth is driven by ease of access to cannabis products owing to its legalization coupled with rising technological advancements. Furthermore, increasing government efforts in the form of initiatives and policies is fuelling the market growth in the state. For instance, in April 2023, Cannabis Business Office announced a partnership with NuProject, a mission-based lender, to launch the Cannabis Business Loan Program. The loan program is expected to provide emerging businesses access to funding and create 239 jobs in the state.
Moreover, the increasing prevalence of cancer in the state, coupled with rising awareness regarding the benefits associated with the use of medical marijuana for cancer treatment, is anticipated to drive growth over the forecast period. According to Colorado Environmental Public Health Tracking, around 25,000 adults in the state are diagnosed, and around 7,600 deaths are caused by cancer every year. Additionally, a study conducted by the University of Colorado has shown that patients suffering from cancer reported pain relief, enhanced sleep cycles, and a reduction in brain fog after consumption of cannabis.
The National Commission on Marijuana and Drug Abuse decriminalized marijuana in 1975. Under the law, adults over the age of 21 years are allowed to possess less than one ounce of cannabis products. Furthermore, the Medical Use of Marijuana Act was passed in 2000 by the voters in the states that allow the possession of medical marijuana among patients suffering from debilitating health conditions. The Marijuana Enforcement Division (MED) of the Colorado Department of Revenue is responsible for the regulation and licensing of cannabis businesses in the state.
The presence of key players, such as TREES CORPORATION, Cannasseur Pueblo West, LivWell Dispensary, The Green Solution, Lightshade, Medicine Man, NATIVE ROOTS, and Starbuds, are adopting partnerships, acquisitions, expansions, new product launches, and collaboration as strategies to expand their geographical footprint and strengthen their market position.
For instance, in December 2022, TREES CORPORATION announced the acquisition of the Green Tree cannabis dispensaries along with manufacturing and cultivation assets in Longmont and Berthoud, Colorado. This acquisition is expected to contribute to the company’s expansion plans in the state. Furthermore, in December 2022, Medicine Man Technologies, a multi-state, vertically operating company, announced the acquisition of Lightshade Labs LLC’s assets located in Aurora and Denver for a total of USD 2.75 million. This acquisition strengthens the company’s geographical presence across New Mexico and Colorado.
Colorado Legal Cannabis Market Report Highlights
The colorado legal cannabis market size is projected to reach USD 5.53 billion by 2030, expanding at a CAGR of 12.9% from 2025 to 2030, according to a report by Grand View Research, Inc. The growth is driven by ease of access to cannabis products owing to its legalization coupled with rising technological advancements. Furthermore, increasing government efforts in the form of initiatives and policies is fuelling the market growth in the state. For instance, in April 2023, Cannabis Business Office announced a partnership with NuProject, a mission-based lender, to launch the Cannabis Business Loan Program. The loan program is expected to provide emerging businesses access to funding and create 239 jobs in the state.
Moreover, the increasing prevalence of cancer in the state, coupled with rising awareness regarding the benefits associated with the use of medical marijuana for cancer treatment, is anticipated to drive growth over the forecast period. According to Colorado Environmental Public Health Tracking, around 25,000 adults in the state are diagnosed, and around 7,600 deaths are caused by cancer every year. Additionally, a study conducted by the University of Colorado has shown that patients suffering from cancer reported pain relief, enhanced sleep cycles, and a reduction in brain fog after consumption of cannabis.
The National Commission on Marijuana and Drug Abuse decriminalized marijuana in 1975. Under the law, adults over the age of 21 years are allowed to possess less than one ounce of cannabis products. Furthermore, the Medical Use of Marijuana Act was passed in 2000 by the voters in the states that allow the possession of medical marijuana among patients suffering from debilitating health conditions. The Marijuana Enforcement Division (MED) of the Colorado Department of Revenue is responsible for the regulation and licensing of cannabis businesses in the state.
The presence of key players, such as TREES CORPORATION, Cannasseur Pueblo West, LivWell Dispensary, The Green Solution, Lightshade, Medicine Man, NATIVE ROOTS, and Starbuds, are adopting partnerships, acquisitions, expansions, new product launches, and collaboration as strategies to expand their geographical footprint and strengthen their market position.
For instance, in December 2022, TREES CORPORATION announced the acquisition of the Green Tree cannabis dispensaries along with manufacturing and cultivation assets in Longmont and Berthoud, Colorado. This acquisition is expected to contribute to the company’s expansion plans in the state. Furthermore, in December 2022, Medicine Man Technologies, a multi-state, vertically operating company, announced the acquisition of Lightshade Labs LLC’s assets located in Aurora and Denver for a total of USD 2.75 million. This acquisition strengthens the company’s geographical presence across New Mexico and Colorado.
Colorado Legal Cannabis Market Report Highlights
- The marijuana segment held the largest revenue share of over 85% in 2024 and is expected to grow at the fastest CAGR over the forecast period
- CBD held the largest revenue share of approximately 65% in 2024. The growth of CBD in the Colorado legal cannabis market is significantly driven by increasing consumer awareness of its therapeutic benefits, coupled with a robust regulatory framework that supports its production and sale.
- The indoor cultivation segment held the largest market share of over 56%. in 2024. Since Colorado legalized recreational cannabis, the demand for high-quality products has surged, leading many growers to adopt indoor cultivation methods to meet this demand.
- The recreational segment held the largest market share of nearly 67% in 2024 and is expected to grow at the fastest CAGR during the forecast period.
Table of Contents
100 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Source
- 1.2.2. Derivatives
- 1.2.3. Cultivation
- 1.2.4. End-use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR’s Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.2.1. Source outlook
- 2.2.2. Derivatives outlook
- 2.2.3. Cultivation outlook
- 2.2.4. End-use outlook
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Colorado Legal Cannabis Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.2.3. Case Study Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.4. Regulatory Landscape
- Chapter 4. Colorado Legal Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)
- 4.1. Definition and Scope
- 4.2. Source Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4. Hemp
- 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2. Hemp CBD
- 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3. Industrial Hemp
- 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Marijuana
- 4.5.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.2. Flower
- 4.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.3. Oil and Tinctures
- 4.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 5. Colorado Legal Cannabis Market Segment Analysis, By Derivatives, 2018 - 2030 (USD Million)
- 5.1. Definition and Scope
- 5.2. Derivatives Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4. CBD
- 5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. THC
- 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Others
- 5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 6. Colorado Legal Cannabis Market Segment Analysis, By Cultivation, 2018 - 2030 (USD Million)
- 6.1. Definition and Scope
- 6.2. Cultivation Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.4. Indoor Cultivation
- 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.5. Outdoor Cultivation
- 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6. Greenhouse Cultivation
- 6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 7. Colorado Legal Cannabis Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
- 7.1. Definition and Scope
- 7.2. End Use Segment Dashboard
- 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.4. Industrial Use
- 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5. Medical Use
- 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.2. Chronic Pain
- 7.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.3. Depression and Anxiety
- 7.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.4. Arthritis
- 7.5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.5. Post Traumatic Stress Disorder (PTSD)
- 7.5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.6. Cancer
- 7.5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.7. Migraines
- 7.5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.8. Epilepsy
- 7.5.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.9. Alzheimer’s
- 7.5.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.10. Multiple Sclerosis
- 7.5.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.11. Amyotrophic Lateral Sclerosis
- 7.5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.12. Tourette’s
- 7.5.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.13. Diabetes
- 7.5.13.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.14. Parkinson's
- 7.5.14.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.15. Glaucoma
- 7.5.15.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.16. Others
- 7.5.16.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6. Recreational Use
- 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, by Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Market Position Analysis
- 8.4. Company Profiles
- 8.4.1. NORTHWEST CANNABIS SOLUTIONS
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Service Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. The Hollingsworth Cannabis Company, LLC
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Service Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Alkaloid Cannabis Company
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Service Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Herbs House
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Service Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Nirvana Cannabis
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Service Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Edgemont Group (Leafwerx )
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Service Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. OLYMPIA WEED COMPANY
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Service Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. Canna West Seattle
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Service Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Grow Op Farms (Phat Panda)
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Service Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Forbidden Farms, LLC
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Service Benchmarking
- 8.4.10.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.